Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3845878

FC(F)(F)c1ccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.56
CYP3A4 P08684 5/20 0.45
HPGD P15428 1/20 0.45
ROCK2 O75116 1/20 0.43
AKT2 P31751 1/20 0.43
AKT3 Q9Y243 1/20 0.43
CLK4 Q9HAZ1 5/20 0.42
TSHR P16473 4/20 0.42
HSD17B10 Q99714 4/20 0.42
RPS6KB1 P23443 3/20 0.42
HIF1A Q16665 3/20 0.42
MAPK1 P28482 3/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C19 P33261 2/20 0.42
LMNA P02545 2/20 0.42
USP2 O75604 2/20 0.42
CYP2D6 P10635 2/20 0.42
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3851562 0.92 AKT1 (0.55) AKT1CYP3A4HPGDCLK4TSHR
Trifluoroacetic Acid SCHEMBL3855290 0.91 AKT1 (0.54) AKT1CYP3A4HPGDCLK4TSHR
Trifluoroacetic Acid SCHEMBL3847292 0.91 AKT1 (0.65) AKT1CYP3A4HPGDCLK4TSHR
Trifluoroacetic Acid SCHEMBL3846494 0.90 AKT1 (0.53) AKT1CYP3A4CLK4TSHRHSD17B10
Trifluoroacetic Acid SCHEMBL3854823 0.89 AKT1 (0.52) AKT1CYP3A4HPGDAKT2AKT3
Trifluoroacetic Acid SCHEMBL5852383 0.88 AKT1 (0.55) AKT1CYP3A4HPGDROCK2CLK4
Trifluoroacetic Acid SCHEMBL3851492 0.88 AKT1 (0.51) AKT1CYP3A4HPGDCLK4TSHR
Trifluoroacetic Acid SCHEMBL3845037 0.86 AKT1 (0.53) AKT1CYP3A4HPGDROCK2CLK4
Trifluoroacetic Acid SCHEMBL3852124 0.85 AKT1 (0.57) AKT1CYP3A4HPGDCLK4TSHR
Trifluoroacetic Acid SCHEMBL3849021 0.85 AKT1 (0.52) AKT1CYP3A4HPGDCLK4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed